Evidence map›Paper›PMID 36231195›Full record

SynthesisInternational journal of environmental research and public health2022

Diet and Systemic Lupus Erythematosus (SLE): From Supplementation to Intervention.

Hanxiao Jiao, Gizem Acar, George A Robinson, Coziana Ciurtin, Elizabeth C Jury, Anastasia Z Kalea

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in International journal of environmental research and public health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 4 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 4 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Review
  9. Article
  10. Review
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Lupus Nephritis from Pathogenesis to New Therapies: An Update.International journal of molecular sciences · 2024
    Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hanxiao JiaoDivision of Medicine, University College London, Rayne Building, London WC1E 6JF, UK.
Gizem AcarDivision of Medicine, University College London, Rayne Building, London WC1E 6JF, UK.ORCID 0000-0003-2399-4530
George A RobinsonCentre for Rheumatology Research, Division of Medicine, University College London, Rayne Building, London W1CE 6JF, UK.ORCID 0000-0001-7473-7652
Coziana CiurtinCentre for Adolescent Rheumatology versus Arthritis, Division of Medicine, University College London, Rayne Building, London W1CE 6JF, UK.ORCID 0000-0002-8911-4113
Elizabeth C JuryCentre for Rheumatology Research, Division of Medicine, University College London, Rayne Building, London W1CE 6JF, UK.ORCID 0000-0002-2389-3396
Anastasia Z KaleaDivision of Medicine, University College London, Rayne Building, London WC1E 6JF, UK.ORCID 0000-0001-5775-3984
University College London · GBArthritis UK · GB

Funding

Versus Arthritis 22856Versus Arthritis 22908
6 · The paper itself

Abstract

backgroundSystemic lupus erythematosus (SLE) is a chronic autoimmune inflammatory disease characterised by immune dysregulation affecting multiple organs. Current anti-inflammatory treatments used in SLE are associated with unwanted side-effects. Dietary supplementation has been suggested as a safe and effective addition to conventional treatment, but evidence of efficacy in SLE or preventing associated comorbidities is uncertain.

methodsWe identified literature on clinical trials focused on nutritional interventions in SLE aiming to improve inflammation and comorbidities. A systematic-type search on Embase, Medline, and the Cochrane Library, was conducted to identify nutritional interventions among SLE patients in the past 15 years that met our inclusion criteria.

resultsWe identified 2754 articles, of which 14 were eligible for inclusion based on our set criteria and were subsequently quality assessed. Vitamin D or E supplementation was associated with respective improvement of inflammatory markers or antibody production, but not disease activity scores in most studies. Despite their expected synergistic actions, the addition of curcumin on vitamin D supplementation had no additional effects on disease activity or inflammatory markers. Trials of omega-3 fatty acid supplementation presented significant reductions in ESR, CRP, disease activity, inflammatory markers, and oxidative stress, and improved lipid levels and endothelial function, while a low glycaemic index (GI) diet showed evidence of reduced weight and improved fatigue in patients.

conclusionsDifferent dietary guidelines can therefore be implicated to target specific SLE symptoms or therapeutic side-effects. This systematic review highlights the scarcity of larger and longer in duration trials with homogenous methodologies and verifiable outcomes to assess disease progression.

Indexed as

CurcuminFatty Acids, Omega-3Lupus Erythematosus, SystemicBiomarkersDietDietary SupplementsHumansVitamin DBiomarkersCurcuminFatty Acids, Omega-3Vitamin Ddietary interventionnutritionomega-3 fatty acidssupplementationsystemic lupus erythematosusvitamin D

Identifiers

PMID36231195
PMCPMC9565311
OpenAlexW4296741136

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.